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INTRODUCTION 
Attention deficit and hyperactivity 
disorder are among the most prevalent 
childhood behavioral disorders. Based on a 
meta-analysis of evaluating parents and 
teachers with a sample size of 14731 
subjects collected from 16 studies, the 
prevalence of this disorder was 8% in 
children aged 7 to 12 years in Iran (95% CI, 
5 to 11%).
1
 In other studies, the prevalence 
of the disorder has been reported to be 3 to 7 
with higher prevalence in males than 
females.
2
 This is a persistent psychiatric 
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ABSTRACT 
Background and aims: Neurofeedback is a relatively new therapy focusing on the core 
symptoms of inattention, impulsivity and hyperactivity. We undertook a meta-analysis to 
estimate the effectiveness of neurofeedback on attention deficit disorder in Iran. 
Methods: International databases as Pubmed, Scopus, ISI, Google Scholar, and national 
databases as SID, Medlib, Iranmedex, Magiran were searched using the terms of 
neurofeedback, attention deficit and hyperactivity. The standardized effect size (SMD) of 
the control group’s mean difference was calculated by the standard deviation integration. 
Data were analyzed using meta-analysis (random effects model). Heterogeneity of studies 
was assessed using I
2
 index and the Der Simonian-Laird method. 
Results: Nine studies were reviewed with a sample size of 204 individuals during 1997 to 
2005 and Neurofeedback’s overall standardized effect size (SMD) on attention deficit 
disorder was significant in the experimental group before and after the intervention 
(SMD=1.14; 95% CI, 0.91-1.38, P=0.001). The SMD was not significant in the control group 
before and after the intervention (SMD=0.09; 95% CI, 0.07-0.24). Meta-regression showed 
no statistically significant relationship between the year of study, sample size and SMD. 
Conclusion: Although international randomized clinical trials have shown that 
neurofeedback is not effective in ADHD treatment, In Iran, results of the studies showed 
that neurofeedback was effective in the treatment of some ADHD’s indicators and 
ineffective in some other ADHD’s indicators. Overall, neurofeedback was effective in the 
treatment of ADHD. 
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disorder characterized by sustained 
symptoms such as inattention or 
hyperactivity and impulsivity each observed 
separately or both together.
3
 The prevalence 
of this disorder has been reported to be 
about 7% in the United States and between 2 
and 29% at international level.
4
 
In recent years, specialists have 
proposed various causes associated with 
attention deficit and hyperactivity disorder.
5
 
Neurological causes are one sort of attention 
deficit and hyperactivity disorder causes are 
also confirmed by numerous studies.
6
 The 
main symptoms of the disease cause 
emotional, family and social problems such 
as poor academic performance, family stress 
and conflicting relationships with peers.
7
 
Similar symptoms of attention deficit 
disorder and learning disorder include 
attention and hyperactivity problems, 
frustration at the lowest level, low  
self-esteem, lack of ethics, disorders in 
social skills, poor academic achievement 
and increasing school dropouts.
8
 
Brain activity can be measured by 
electroencephalography (EEG). This 
technique is called EEG-NF. The aim of 
EEG-NF is obtaining control over certain 
aspects of the brain's electrical activity 
through the use of positive reinforcement 
and self-regulation skills in daily life.
9,10
 
Neurofeedback is a special form of 
biofeedback in which brain waves are used 
as feedback. In this method, sensors called 
electrodes are connected to the patient's 
head and the received information are 
provided for the patient and therapist 
through two separate monitors.
11
 
Neurofeedback treatment was first proposed 
by Lowell Lobar. The basic idea is that, by 
observing its abnormal waves, the brain 
learns to modify itself. This is done in the 
treatment process based on principles of 
learning.
12
 Neurofeedback is a tool equipped 
with a computer system used to run 
neurofeedback training method or 
Neurofeedback. This tool uses observer 
equipment connected to the body (electrode) 
to provide people with information about 
some of their biological body functions.
13
 
Neurofeedback is a neuropsychological 
training and treatment method so that an 
individual can learn to alter brain electrical 
activity in an operant conditioning process.
14
 
It is also a technique in which people learn 
to change their pattern of brain waves 
through operant conditioning.
15
 The goal of 
neurofeedback training is modifying 
abnormal EEG which results in the 
promotion of an individual’s associated 
behavioral and cognitive performance.
16
 
Neurofeedback significantly decreases 
cognitive and behavioral symptoms of 
ADHD and has the effectiveness of 
medication and even being an alternative to 
stimulant drugs.
17
 In total, in explaining the 
effectiveness of neurofeedback; it can be 
asserted that the human brain is capable of 
healing itself. It refers to the ability to learn 
or relearn the self-regulating mechanisms of 
brain waves which have an important role in 
normal brain functioning.
13
 Drug therapy 
and neurofeedback have improved attention, 
speed, and accuracy.
18
 Neurofeedback 
effectiveness is based on a learning process 
and operant conditioning, so the duration of 
treatment is usually long-term.
19
 
The number of clinical trials on the use 
of neurofeedback in treating hyperactivity 
disorders is increasing. Although clinical 
reports and free treatment studies consider 
using neurofeedback effect in treating 
ADHD and show that neurofeedback 
improves attention, behavior control, 
increases cortical activity and enhances 
intelligence test scores and academic 
achievement, double-blind clinical trials and 
meta-analysis studies with strict criteria, do 
not consider using neurofeedback effect in 
ADHD treatment.
10,20,21
 
Several studies have been conducted on 
“Effects of neurofeedback on attention 
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deficit disorder” in different regions of Iran, 
each reporting a different result. Some of 
these studies consider neurofeedback 
effective in attention-deficit disorder while 
others do not. However, there is not yet a 
total estimate of the effectiveness of 
neurofeedback on attention-deficit disorder 
in Iranian society. Hence, doing a systematic 
review and meta-analysis study is necessary 
to collect all the evidence and data about the 
effectiveness of neurofeedback on  
attention-deficit disorder. The present study 
aimed at evaluating the effectiveness of 
neurofeedback on attention-deficit disorder 
in Iran through systematic review and  
meta-analysis. 
 
METHODS 
Nowadays, systematic reviews and  
meta-analysis studies and reports are done on 
the basis of guidelines agreed upon by the 
world's top medical journals’ editors, 
statisticians, epidemiologists and researchers 
of the world. In a meeting held in 2005 
attended by 29 members among journal 
reviewers, chief-editors, clinicians, statistician, 
epidemiologists, a checklist of 27 items, 
known as the PRISMA guidelines, was 
written for reporting systematic review and 
meta-analysis studies. This article is written 
based on the PRISMA guidelines.
22
 
Articles which had words like 
population, intervention, comparators, 
outcomes, and study designs of interest in 
their titles were selected for inclusion in the 
meta-analysis. Articles that were published 
in English and Farsi were included and no 
time limitation was considered for an 
articles’ publication time. 
This is a meta-analysis study aimed at 
evaluating the effectiveness of 
neurofeedback on attention-deficit disorder 
in Iran. The reviews were done through 
internet search and manual search of 
documents in the library of Tehran 
University of Medical Sciences. The 
databases of Iranmedex, SID, Magiran, 
Irandoc, Medlib, IranPsych, Science Direct, 
ISI, PubMed, Scopus were searched using 
internet. The search included theses, 
national and international scientific journals, 
and papers presented at congresses and 
organizational reports. In searching national 
databases, it was conducted only by 
searching for keywords of neurofeedback to 
gain high sensitivity, attention deficit and 
hyperactivity because some sites did not 
show sensitivity to search operators of  
(or, and, not). To search international 
databases, keywords of “Hyperactivity 
Disorder”, “Attention Deficit”, and 
“Neurofeedback” were used. The standard 
key words in Mesh were used. The strategy 
of (Attention Deficit and Neurofeedback) 
was used to search. In addition, the 
references of the selected articles were 
screened for finding relevant studies. 
First, a list of titles and abstracts of all 
searched papers in national databases was 
prepared by two researchers independently 
(Mandana Kourosh). Then, articles with 
repetitive titles were excluded. Next, 
articles’ abstracts were reviewed for finding 
appropriate studies. 
Study inclusion criteria were: 1- Studies 
conducted before and after. 2- Studies 
evaluating the effectiveness of neurofeedback 
on attention deficit disorder. Exclusion criteria 
were: 1- Non-related studies in terms of study 
method and research topic. 2- Studies, which 
did not have enough information. 3- Studies 
which did not mention the mean and standard 
deviation before and after the intervention.  
4- Studies that have low quality due to the 
STROBE checklist (Strengthening the 
reporting of observational studies in 
epidemiology).
23
 The quality of the studies 
was evaluated using the STROBE checklist. 
The checklist has 22 sections that cover 
different parts of a report. Each section was 
given one point and higher points were given 
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to other sections that we considered more 
important. 
To reduce bias in reporting and error in 
data collection, two researchers 
independently extracted data using a 
standardized data collection form that was 
already prepared. The form was first 
designed by the study team and included the 
following items: The author’s name, title of 
study, year of publication, city of study, 
journal name, study design, ADHD 
assessment method, ADHD assessment tool, 
duration of treatment, duration of each 
session, the studied age group, sample size, 
mean and standard deviation before and 
after the intervention. 
The questionnaires used in this study 
included Wechsler inventories, Connors, 
Posner, Padua, LDES, Iran cpt, tova, and the 
index of theta to beta ratio. 
Wechsler intelligence scale for 
children: This scale is to measure 
intelligence. It is composed of 12 subtests 
and two of them are used solely as an 
alternative or supplement. This test has two 
practical and verbal scales.
24
 Conners scale: 
This scale has been accepted as an 
appropriate screening instrument to search 
for (probable sick children) as well as a 
measure of the severity of symptoms in 
patients with ADHD.
25
 Posner test: This 
test is the most common experimental 
model used for the study of visual-spatial 
attention.
26
 Padua inventory: It was 
developed by Sanavio in Italy in 1980 in 
the country which has 60 articles used to 
assess the severity of symptoms in clinical 
and normal participants.
27
 LDES test: This 
test is used to diagnose learning disabilities 
and include measures of listening, thinking, 
speaking, reading, writing, spelling and 
calculation. 
Data were entered from the checklist to 
the Excel software and transferred from the 
Excel software to SPSS software and a 
preliminary analysis of the data was 
performed with SPSS. Sincemeta-analysis 
was not possible with SPSS software, data 
were transferred to the STATA software 
(version 11.2) and meta-analysis was 
performed with this software. 
As the attention deficit’s average score 
in all studies before and after the 
intervention was measured in control and 
experimental groups, the size of the effect 
(Effect Size) is calculated as follows: 
 
 
 
Where, ESE= the neurofeedback group effect 
size 
ESC= the control group effect size 
SD= common variance 
SMD= standardized overall effect size 
 
 
 
Where, S1
2
= neurofeedback group variance 
S2
2
= control group variance 
n1= the number of samples in the 
neurofeedback group 
n2= the number of samples in the control 
group 
 
Given that decreasing the score of some 
hyperactivity indicators such as inattention, 
impulsivity, responsiveness volatilities 
indicates an improvement of ADHD and 
increasing the score of some indicators such 
as planning, simultaneous processing and 
verbal and practical intelligence indicate the 
effectiveness of neurofeedback, the order of 
entering some variables was reversed to 
align the size effect. Heterogeneity of 
studies was assessed using I
2
 index and the 
Der Simonian-Laird method. Due to the 
heterogeneity between studies, the overall 
effect size was assessed using the random 
effects model. The funnel plot and Egger 
test were used to evaluate publication bias. 
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The significance level of P<0.05 was 
considered as significance level in test of 
hypnosis. 
 
RESULTS 
In the first phase of the search,  
20 articles were selected and after reviewing 
the titles, only 14 relevant articles were 
identified and included in the second phase 
which was the evaluation of abstracts. After 
reading the full text of articles, one article 
was excluded from the study because its 
sample size was only two subjects.
28
 
Sajadi et al., study was not included in 
the analysis because the mean and standard 
deviation were not mentioned in the control 
and experimental groups.
29
 
Finally, 8 appropriate articles were 
entered into the meta-analysis stage. The 
flowchart which shows the process of study 
selection is presented in below (Figure 1). 
The description of studies that met our 
eligibility criteria are presented in Table 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Results of the systematic literature search 
4 of additional 
records identified 
through other sources 
21 of records screened 
20 of records identified through 
database searching in Pubmed, 
Sid, Magiran, Iranmedex Identification 
3 of records after 
duplicates removed 
8 of records excluded 
Screening 
Eligibility 13 of full-text articles 
assessed for eligibility 5 of full-text articles excluded 
9 of studies included in 
quantitative synthesis 
(meta-analysis) 
9 of studies included 
in qualitative 
synthesis 
Included 
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Table 1: Included articles’ specifications into the meta-analysis on the effectiveness of 
neurofeedback on attention-deficit disorder in Iran 
Reference Researcher Questionnaire Study title Number of 
sessions 
Session 
duration 
Year 
30 
Hamid 
Yaghoubi 
Wechsler 
Intelligence 
The effectiveness of neurofeedback on 
cognitive function in children with 
hyperactivity/attention deficit disorder 
30 45 min 2007 
31 
Hamid 
Yaghoubi 
Wechsler 
Intelligence and 
Conner's test 
Comparing the efficacy of Neurofeedback, 
Ritalin and combination therapy in reducing 
symptoms in children with 
hyperactivity/attention deficit disorder (ADHD) 
30  2009 
32 
Fariba 
Nabavi 
Alagha 
Posner test The effectiveness of neurofeedback training on 
cognitive function 
20 45 min 2013 
29 
Alireza 
Sajadi 
Posner test The effect of neurofeedback on the treatment of 
children’s learning disorder in mathematics 
course in third grade elementary school 
20 30 min 2013 
33 
Mohsen 
Jadidi 
Conner's test Interventions challenge: To what extent each 
parent management training interventions, 
neurofeedback and Ritalin improve 
hyperactivity/attention deficit disorder and 
Parenting Stress Index 
4 120 min 2010 
34 
Narges 
Nourizadeh 
LDES Effects of neurofeedback on learning deficits 
associated with attention deficit/hyperactivity 
disorder 
40 60 min 2012 
35 
Mohammad 
Narimani 
Conner's test Effects of neurofeedback training on reducing 
ADHD symptoms in female students 
20 40 min 2012 
6 
Somayeh 
Sadati 
Sandford and 
Turner test 
Evaluating the effectiveness of neurofeedback 
treatment on behavioral inhibition and 
impulsivity among students having attention 
deficit and hyperactivity disorder 
30  2013 
36 
Hossain 
Vahedi 
Tova test Comparing the effect of neurofeedback 
treatment and medication on an ongoing 
performance in hyperactivity attention deficit 
disorder 
20  2012 
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Table 2: Comparison scores experiment and control group before and after intervention 
Firs 
author 
Symptoms 
code 
Sample size 
in control 
group 
Sample size in 
experiment 
group 
Control Experiment 
Before After Before After 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Yaghubi1 1 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Yaghubi1 2 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Yaghubi1 3 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Besharat 4 8 8 3.88±1.4 3.57±1.14 4.1±1.08 3.88±1.14 
Besharat 5 8 8 3.43±0.71 3.34±0.71 3.42±0.97 3.43±0.71 
Yaghubi2 6 8 8 27.75±10.80 27.75±10.90 11.75±10.80 6.25±10.9 
Yaghubi2 7 14 14 33.50±23.50 32.75±14.90 41.50±23.50 17.50±14.9. 
Yaghubi2 8 8 8 0.76±0.15 0.75±0.11 0.67±0.15 0.60±0.11 
Yaghubi2 9 8 8 0.34±0.13 0.35±0.10 0.29±0.13 0.26±0.10 
Yaghubi2 10 8 8 69.75±10.60 78.50±21.40 73.00±10.60 47.50±21.4 
Yaghubi2 11 14 14 29.50±4.40 26.75±6.40 29.75±4.40 18.50±6.40 
Yaghubi2 12 8 8 11.25±2.00 10.50±3.20 12.75±2.00 6.50±3.20 
Yaghubi2 13 8 8 24.00±2.80 21.75±5.30 23.00±2.80 14.25±5.30 
Yaghubi2 14 8 8 16.50±2.80 16.50±4.50 15.00±2.80 10.75±4.50 
Narimani 16 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Narimani 17 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Narimani 18 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Narimani 19 14 14     
Narimani 20 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Narimani 21 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Narimani 22 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Norizadeh 24 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Norizadeh 25 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Norizadeh 26 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Norizadeh 28 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Norizadeh 29 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Norizadeh 30 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Norizadeh 32 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Norizadeh 33 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Norizadeh 34 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Haghighi 36 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Sadati S 37 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Sadati S 38 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
Sadati S 40 8 8 108.50±11.40 106.00±12.20 117.75±12.40 111.00±7.30 
Vahedi H 41 8 8 106.50±6.60 105.00±7.50 111.50±5.20 106.50±3.00 
Vahedi H 42 8 8 109.25±7.70 106.75±9.10 116.25±8.80 110.50±3.30 
 
9 studies were reviewed with a sample 
size of 204 individuals during 1997 to 2005 
and the effect size was 0.09 in the control 
group before and after the intervention 
(95% CI, 0.07-0.24) which was not 
statistically significant (P>0.263)  
(Figure 2). As shown in Figure 2, there was 
no significant difference between any of the 
criteria for ADHD before and after the 
intervention in the control group. The 
heterogeneity of the studies was very high 
(I
2
=99%, P=0.001). High heterogeneity 
index showed that the results of studies 
were very different; so, random effects 
model was used to combine the results of 
studies (Figure 2). 
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NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.999)
Narimani (2012)
Haghighi (2012)
Yaghubi2 (2008)
Besharat (2012)
Yaghubi1 (2007)
Narimani (2012)
Narimani (2012)
Yaghubi2 (2008)
Narimani (2012)
Yaghubi2 (2008)
Besharat (2012)
Yaghubi2 (2008)
Yaghubi2 (2008)
Yaghubi1 (2007)
ID
Narimani (2012)
Narimani (2012)
Yaghubi2 (2008)
Yaghubi2 (2008)
Yaghubi2 (2008)
Narimani (2012)
Yaghubi1 (2007)
Yaghubi2 (2008)
Narimani (2012)
Study
0.09 (-0.07, 0.24)
-0.01 (-0.68, 0.66)
0.08 (-0.72, 0.88)
0.00 (-0.69, 0.69)
0.27 (-0.71, 1.26)
0.21 (-0.77, 1.19)
0.09 (-0.58, 0.76)
0.05 (-0.62, 0.73)
-0.52 (-1.22, 0.19)
0.09 (-0.58, 0.76)
0.50 (-0.20, 1.21)
0.13 (-0.85, 1.11)
-0.09 (-0.78, 0.61)
0.28 (-0.42, 0.98)
0.21 (-0.77, 1.20)
SMD (95% CI)
0.05 (-0.62, 0.72)
0.06 (-0.61, 0.74)
0.04 (-0.65, 0.73)
0.00 (-0.69, 0.69)
0.08 (-0.62, 0.77)
-0.01 (-0.68, 0.67)
0.30 (-0.69, 1.28)
0.53 (-0.18, 1.24)
0.03 (-0.64, 0.70)
100.00
5.15
3.64
4.85
2.40
2.41
5.15
5.15
4.68
5.15
4.69
2.42
4.85
4.80
2.41
Weight
5.15
5.15
4.85
4.85
4.85
5.15
2.40
4.68
5.15
%
  
0-1.28 1.28
 
Figure 2: Forestplots of Standardized Mean Difference (SMD), and homogeneity statistics for 
the ADHD symptoms in the control group before and after intervention 
The diamond shows the pooled of SMD in all studies. 
 
Figure 3 showed that the effect size 
was 0.10 in control and experimental 
groups before the intervention (95% CI, 
0.15-0.34) which was not statistically 
significant (P=0.42). As shown in Figure 3, 
there was no significant difference in none 
of the criteria for ADHD before the 
intervention in the experimental and control 
groups except for the Conners Index in the 
study of Yaghoubi and the number of 
correct answers index in the study of 
Narimani (Figure 3). The heterogeneity of 
the studies was moderate (I
2
=59.6%, 
P=0.001). Moderate heterogeneity index 
showed that the results of studies were 
different; hence, random effects model was 
used to combine the results of studies 
(Figure 3). 
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NOTE: Weights are from random effects analysis
Overall  (I-squared = 59.6%, p = 0.000)
Narimani (2012)
Yaghubi2 (2008)
Yaghubi2 (2008)
Narimani (2012)
Narimani (2012)
Narimani (2012)
Narimani (2012)
ID
Yaghubi1 (2007)
Narimani (2012)
Yaghubi2 (2008)
Besharat (2012)
Narimani (2012)
Yaghubi2 (2008)
Yaghubi2 (2008)
Narimani (2012)
Yaghubi1 (2007)
Yaghubi2 (2008)
Yaghubi2 (2008)
Yaghubi2 (2008)
Besharat (2012)
Haghighi (2012)
Yaghubi2 (2008)
Yaghubi1 (2007)
Study
-0.10 (-0.34, 0.15)
0.13 (-0.54, 0.80)
0.38 (-0.32, 1.08)
-0.34 (-1.04, 0.36)
0.20 (-0.48, 0.87)
0.02 (-0.65, 0.69)
-0.36 (-1.03, 0.32)
0.13 (-0.54, 0.81)
SMD (95% CI)
-0.84 (-1.87, 0.19)
-0.57 (-1.25, 0.12)
0.54 (-0.17, 1.24)
0.01 (-0.84, 0.86)
-1.62 (-2.40, -0.84)
-0.75 (-1.47, -0.03)
0.60 (-0.11, 1.31)
0.07 (-0.61, 0.74)
-0.85 (-1.88, 0.18)
-0.06 (-0.75, 0.64)
1.48 (0.69, 2.27)
0.36 (-0.34, 1.06)
-0.12 (-0.97, 0.73)
-0.27 (-1.07, 0.53)
-0.31 (-1.00, 0.39)
-0.78 (-1.80, 0.24)
100.00
4.75
4.62
4.62
4.74
4.75
4.72
4.75
Weight
3.21
4.68
4.58
3.92
4.23
4.52
4.57
4.75
3.21
4.65
4.19
4.62
3.92
4.12
4.63
3.24
%
  
0-2.4 2.4
Figure 3: Forestplots of Standardized Mean Difference (SMD), and homogeneity statistics for 
the ADHD symptoms in the experimental group and the control group before intervention 
The diamond shows the pooled of SMD in all studies. 
 
Comparing the indicators of hyperactivity 
before and after the study in the 8 studies that 
evaluated the effectiveness of neurofeedback 
on ADHD with the control group showed that 
the overall neurofeedback effect was 
significant. The standardized effect size was 
estimated to be 1.14 (95% CI, 1.38-0.91) 
which was statistically significant (P=0.000) 
(Figure 4). Figure 4 shows that the study of 
Jacob evaluated the three indicators of 
practical, verbal and overall intelligence and 
neurofeedback only increase practical 
intelligence score significantly (from 106.5 to 
111.5), but had no significant impact on the 
overall and verbal intelligence.
30
 Yaghoubi 
compared the effectiveness of neurofeedback 
with other treatment methods (Neurofeedback 
and Ritalin) using Conners and Iran Tova test 
and results showed that neurofeedback was 
effective in the impulsivity index of Iran Tova 
test (17.5-41.5).
31
 However, neurofeedback 
was not significantly effective in indexes of 
response time, inattention and response 
fluctuations. In Conner's test (Figure 4), 
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neurofeedback had a significant effect on all 
test indexes (hyperactivity, impulsivity, 
learning disorders, conduct disorder, and all 
Conners). In Figure 4, when linear segments 
do not cut a perpendicular to zero, their 
effect is significant and vice versa. 
Nurizadeh showed that neurofeedback was 
significant only in attention index not in 
other indicators. In the study of Sadatipour 
et al., neurofeedback had a significant effect 
on ADHD indexes. By combining all studies 
using random-effects model, neurofeedback 
meta-analysis was significant on ADHD 
indexes (Figure 4). 
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Figure 4: Forestplots of Standardized Mean Difference (SMD), and homogeneity statistics for 
the ADHD symptoms before and after intervention in the experimental group 
The diamond shows the pooled of SMD in all studies. 
 
The heterogeneity of the studies was 
high (I
2
=71.9%, P=0.001). High 
heterogeneity index showed that the results 
of studies were different; hence, random 
effects model was used to combine the 
results of studies (Figure 4). Standardized 
effect size of neurofeedback attention 
deficit disorder indexes was calculated in 
the experimental group and the control 
group after the intervention 1.45 (95% CI, 
1.6-1.84) which was statistically significant 
(P=0.001) (Figure 5). 
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Figure 5: Forestplots of Standardized Mean Difference (SMD), and homogeneity statistics for 
the ADHD symptoms after intervention in the experimental group and control group 
The diamond shows the pooled of SMD in all studies. 
 
Meta-regression model showed no 
significant relationship between years of study 
and neurofeedback effect size (P=0.719). 
There was a direct relationship between 
sample size and neurofeedback effect size 
which means that studies with larger sample 
sizes showed a more significant neurofeedback 
effect. This relationship is statistically 
significant with a 10% error, but not 
significant with error of 5% (P=0.06). 
 
Begg's funnel plot with pseudo 95% confidence limits
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D
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Figure 6: Publication bias plot effect of Neurofeedback on ADHD 
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Symptoms code 
1 Verbal IQ 
2 Practical IQ 
3 Total IQ 
4 Theta to beta in CZ 
5 Theta to beta in FZ 
6 Attention-deficit 
7 Impulsiveness 
8 Response time 
9 Fluctuation response 
10 Total score of Kanerz 
11 Attention-deficit 
12 Impulsiveness 
13 Learning disorder 
14 Conduct disorder 
15 Deletion error 
16 Presentation error 
17 Correct response 
18 Response time 
19 Inattention 
20 Attention-deficit 
21 Impulsiveness 
22 Attention-deficit 
23 Hear 
24 Think 
25 Speak 
26 Read 
27 Write 
28 Spell 
29 Mathematic 
30 Total score 
31 Planning 
32 Simultaneously process 
33 Attention 
34 Series process 
35 Total score 
36 Total score of attention-deficit 
37 Behavior 
38 Vision behavior 
39 Hear behavior 
40 Accuracy in response 
 
Publication bias figure and Egger test 
show that the effect of publication bias is 
statistically significant (P=0.001). It seems 
that studies which did not show 
neurofeedback effectiveness to be 
significantly effective were less likely to be 
published and included in this study. 
 
DISCUSSION 
Nine studies were reviewed with a 
sample size of 204 individuals in the 
control and experimental groups during 
1997 to 2005 and the neurofeedback 
overall effect was significant on attention 
deficit disorder (SMD=1.14, P<0.001). In 
the control group, there was not a 
significant difference between measures of 
hyperactivity before and after the study. 
So, we can say that Iran’s neurofeedback 
studies had an acceptable design since it is 
expected that people who have not 
received any self-treatment do not 
improve. Also, there was not a significant 
difference between hyperactivity indexes 
before the intervention in the 
neurofeedback and control groups. If 
hyperactive individuals are included in the 
experimental and control groups randomly, 
we expect no significant difference 
between the indexes in the two groups 
before the treatment. Among the 43 
indexes evaluated in all the studies, only 
two indexes were significant before the 
intervention between the control and 
experimental groups and there was no 
significant difference in the rest of the 
indexes. By combining the effect size in 
all studies, there was not a significant 
difference between the experimental and 
control groups before the intervention 
which showed the suitability of the design. 
Yaghoubi investigated the three 
indexes of practical, verbal and overall 
intelligence and neurofeedback only 
increased the practical intelligence score 
significantly, but the effect on the verbal 
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and overall intelligence was not 
significant.
31
 In another study, Jacob et al., 
compared the effectiveness of 
neurofeedback with other treatment 
methods (Neurofeedback and Ritalin) 
using the Conners test and Iran Tova test 
and results showed that neurofeedback was 
effective in the impulsivity index of Iran 
Tova test.
31
 However, neurofeedback was 
not significantly effective in indexes of 
response time, inattention and response 
fluctuations. In Conner's test, 
neurofeedback had a significant effect on 
all test indexes (hyperactivity, impulsivity, 
learning disorders, conduct disorder, and 
all Conners). By combining all studies 
using random-effects model, 
neurofeedback meta-analysis was 
significant on ADHD indexes (Figure 4). 
Hilliard analyzed the DNA of brain 
waves during neurofeedback training in 
people with attention deficit/ 
hyperactivity. This study showed that 
neurofeedback is an effective treatment for 
ADHD.
32
 Gevensleben et al., randomly 
divided 94 children (6 to 12 years) with 
ADHD into two groups of drug therapy 
and neurofeedback and showed that 
neurofeedback can improve attention and 
self-management abilities in children with 
attention deficit hyperactivity disorder.
37
 
Also, Internal investigations confirm the 
effectiveness of neurofeedback in treating 
the symptoms of hyperactivity and 
attention deficit. For example, Yaghoubi et 
al., demonstrated that neurofeedback 
training with Ritalin treatment is effective 
in reducing the symptoms of attention 
deficit hyperactivity disorder in children.
31
 
Logemann studied neurofeedback 
effect on attention deficit-hyperactivity 
disorder in children and results showed 
that neurofeedback had no impact on the 
two groups.
38
 Although clinical reports 
and free treatment studies consider using 
neurofeedback effective in treating ADHD 
and have shown that neurofeedback 
improves attention, behavior control, 
increases cortical activity and enhances 
intelligence test scores and academic 
achievement, double-blind clinical trials 
and meta-analyzes with strict criteria using 
neurofeedback not effective in ADHD 
treatment.
10,20,21
 
Micoulaud-Franchi carried out a  
meta-analysis study in France and 
combined the results of five clinical trials 
that have assessed the effectiveness of 
neurofeedback on ADHD and similar 
SMD index of this study was calculated. 
The results showed that parents viewed 
neurofeedback significantly effective on 
hyperactivity and attention deficit while 
teachers did not view neurofeedback 
significantly effective on hyperactivity and 
attention deficit.
39
 Neurofeedback effect 
size in ADHD total score in parents’ view 
in Micoulaud-Franchi’s study was lower 
than our study (SMD=-0.49). 
Given the significance of the effect of 
publication bias in studies conducted in 
Iran, those which have shown significant 
effects of neurofeedback on ADHD have 
been more likely to be published and this 
might be one reason that the effect of 
neurofeedback on ADHD in Iran was more 
than the meta-analysis study conducted in 
France. Well-designed studies are needed 
to be conducted to make the various forms 
of neurofeedback so that it provides 
comprehensive scientific evidence about 
the effectiveness or lack of effectiveness 
of neurofeedback in treatment of attention 
deficit hyperactivity disorder.
20
 
The limitations of this study include 
not using the same tool for the assessment 
of ADHD, the low number of studies, lack 
of control group in some studies, lack of 
uniform reporting of studies (mean and 
standard deviations were not mentioned in 
some studies and only P-value was listed) 
and less publishing chance of articles that 
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did not report significant effects of 
neurofeedback on ADHD which created 
publication bias. 
 
CONCLUSION 
Despite the inconsistency in the results 
of studies about the effectiveness of 
neurofeedback on the treatment of 
hyperactivity in Iran, the results of this 
meta-analysis indicated that neurofeedback 
has a significant effect on ADHD treatment. 
Therefore, the use of neurofeedback is 
recommended for ADHD treatment and 
double-blind trials are suggested to 
investigate this issue meticulously. 
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